iBio (IBIO) Total Debt (2020 - 2025)
iBio's (IBIO) quarterly Total Debt came in at $16000.0 in Q3 2025, down 98.2% year-on-year from $888000.0 in Q3 2024, and down 87.5% on a QoQ basis from $128000.0 in Q2 2025.
iBio (IBIO) Total Debt (2020 - 2025) Analysis & Trends
iBio (IBIO) has 6 years of Total Debt data on file, last reported at $16000.0 in Q3 2025.
- On a quarterly basis, Total Debt fell 98.2% year-over-year to $16000.0 in Q3 2025; TTM through Sep 2025 was $16000.0, a 98.2% decrease from a year earlier, with the FY2025 full-year figure at $128000.0, down 86.44% from the prior year.
- Total Debt for Q3 2025 stood at $16000.0, down from $128000.0 in the prior quarter.
- Over the last five years, Total Debt for IBIO reached as high as $22.1 million in Q1 2022 and fell as low as $16000.0 in Q3 2025.
- Historically, Total Debt has averaged $4.7 million across 5 years, with a median of $599500.0 in 2023.
- Across the five-year window, Total Debt surged 64958.82% in 2022 and tumbled 98.2% in 2025, its largest moves.
- Year by year, Total Debt stood at $22.1 million in 2021, then gained by 0.3% to $22.1 million in 2022, then slumped by 98.19% to $401000.0 in 2023, then jumped by 99.0% to $798000.0 in 2024, then slumped by 97.99% to $16000.0 in 2025.
- Per Business Quant data, the three most recent Total Debt figures were $16000.0 in Q3 2025, $128000.0 in Q2 2025, and $110000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,741.39 Bn | 66,741.11 Bn | - | - |
| 2 | Nanobiotix | 1,913.26 Bn | 1,913.20 Bn | - | 110.96 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.02 Bn | 466.23 Bn | 1.35 Bn | 959.06 Mn |
| 5 | Vertex Pharmaceuticals | 122.17 Bn | 114.92 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.85 Bn | 61.10 Bn | 3.31 Bn | 1.99 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.60 Bn | 50.42 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.39 Bn | 34.38 Bn | 959.66 Mn | - |
| 10 | iBio | 174.62 Mn | 174.62 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 16,000.00 |
| Jun 30, 2025 | 128,000.00 |
| Mar 31, 2025 | 110,000.00 |
| Dec 31, 2024 | 798,000.00 |
| Sep 30, 2024 | 888,000.00 |
| Jun 30, 2024 | 944,000.00 |
| Jun 30, 2023 | 401,000.00 |
| Mar 31, 2022 | 22.12 Mn |
| Dec 31, 2021 | 22.05 Mn |
| Mar 31, 2021 | 34,000.00 |
| Dec 31, 2020 | 135,000.00 |
| Sep 30, 2020 | 238,000.00 |
| Jun 30, 2020 | 339,000.00 |